Understanding environmental risks for blood cancers
Mapping the blood cancer exposome for environmental risk profiles of mature B-cell neoplasms
This study is looking at how things in our environment might increase the risk of developing certain blood cancers, like non-Hodgkin lymphoma and multiple myeloma, by analyzing blood samples from patients to find clues that could help us understand this connection better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10810720 on NIH RePORTER |
What this research studies
This research investigates how environmental factors contribute to the risk of developing mature B-cell neoplasms, such as non-Hodgkin lymphoma and multiple myeloma. By using advanced mass spectrometry techniques, the study aims to identify and characterize the cumulative environmental exposures that may influence the development of these cancers. Patients will be involved in a nested case-control study, where their blood samples will be analyzed to uncover potential biomarkers linked to these diseases. The goal is to provide a clearer understanding of how environmental factors interact with genetic predispositions to affect cancer risk.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a family history of blood cancers or those who have been exposed to various environmental factors.
Not a fit: Patients with blood cancers that are not classified as mature B-cell neoplasms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention strategies and targeted interventions for patients at risk of blood cancers.
How similar studies have performed: While the approach of mapping the exposome is innovative, similar studies have shown promise in identifying environmental risk factors for other cancers.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Walker, Douglas Ian — Emory University
- Study coordinator: Walker, Douglas Ian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.